BACKGROUND: The frequency of papillary muscle infarction (PapMI) without rupture has not been fully investigated in vivo. Furthermore, the relationship between papillary muscle dysfunction and mitral regurgitation (MR) has been controversial in patients with ST-segment elevation myocardial infarction. Therefore, the aim of this study was to assess the frequency and clinical characteristics of PapMI without rupture using late gadolinium-enhanced magnetic resonance imaging (MRI) in patients with ST-segment elevation myocardial infarction. METHODS AND RESULTS: One hundred eighteen ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention underwent cardiac MRI twice 9±4 days and 8±1 months (n=104) after myocardial infarction. MR was categorized by echocardiography. Of these patients, 40% were found to have late gadolinium enhancement of papillary muscle, in which the posterior papillary muscle was involved more frequently than the anterior papillary muscle (77% versus 26%; P<0.001). PapMI was encountered more frequently in patients with left circumflex and right coronary artery lesions compared with left anterior descending artery lesion (78%, 48%, and 13%; P<0.001). By multiple logistic regression analysis, only coaptation height was identified as an independent predictor of the presence of MR. The second cardiac magnetic resonance imaging showed that the infarct size had a positive correlation with left ventricular end-diastolic volume (r=0.41, P<0.001) and that PapMI was not associated with left ventricular remodeling (P=0.31). Deterioration of MR was not observed in patients with PapMI. CONCLUSIONS: PapMI is more frequent than previously thought yet appears to have significant clinical latency. The size of the myocardial infarction, but not the presence of PapMI, seems to affect left ventricular remodeling, and PapMI is not obligatorily associated with MR.
BACKGROUND: The frequency of papillary muscle infarction (PapMI) without rupture has not been fully investigated in vivo. Furthermore, the relationship between papillary muscle dysfunction and mitral regurgitation (MR) has been controversial in patients with ST-segment elevation myocardial infarction. Therefore, the aim of this study was to assess the frequency and clinical characteristics of PapMI without rupture using late gadolinium-enhanced magnetic resonance imaging (MRI) in patients with ST-segment elevation myocardial infarction. METHODS AND RESULTS: One hundred eighteen ST-segment elevation myocardial infarctionpatients with primary percutaneous coronary intervention underwent cardiac MRI twice 9±4 days and 8±1 months (n=104) after myocardial infarction. MR was categorized by echocardiography. Of these patients, 40% were found to have late gadolinium enhancement of papillary muscle, in which the posterior papillary muscle was involved more frequently than the anterior papillary muscle (77% versus 26%; P<0.001). PapMI was encountered more frequently in patients with left circumflex and right coronary artery lesions compared with left anterior descending artery lesion (78%, 48%, and 13%; P<0.001). By multiple logistic regression analysis, only coaptation height was identified as an independent predictor of the presence of MR. The second cardiac magnetic resonance imaging showed that the infarct size had a positive correlation with left ventricular end-diastolic volume (r=0.41, P<0.001) and that PapMI was not associated with left ventricular remodeling (P=0.31). Deterioration of MR was not observed in patients with PapMI. CONCLUSIONS:PapMI is more frequent than previously thought yet appears to have significant clinical latency. The size of the myocardial infarction, but not the presence of PapMI, seems to affect left ventricular remodeling, and PapMI is not obligatorily associated with MR.
Authors: Gert Klug; Hans-Josef Feistritzer; Sebastian J Reinstadler; Martin Reindl; Christina Tiller; Magdalena Holzknecht; Agnes Mayr; Silvana Müller; Axel Bauer; Bernhard Metzler Journal: Int J Cardiovasc Imaging Date: 2019-11-09 Impact factor: 2.357
Authors: Neil K Mehta; Jiwon Kim; Jonathan Y Siden; Sara Rodriguez-Diego; Javid Alakbarli; Antonino Di Franco; Jonathan W Weinsaft Journal: J Thorac Dis Date: 2017-04 Impact factor: 2.895
Authors: Jason S Chinitz; Debbie Chen; Parag Goyal; Sean Wilson; Fahmida Islam; Thanh Nguyen; Yi Wang; Sandra Hurtado-Rua; Lauren Simprini; Matthew Cham; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft Journal: JACC Cardiovasc Imaging Date: 2013-02
Authors: Jonathan D Kochav; Jiwon Kim; Robert Judd; Han W Kim; Igor Klem; John Heitner; Dipan Shah; Chetan Shenoy; Afshin Farzaneh-Far; Venkateshwar Polsani; Ramsey Kalil; Pablo Villar-Calle; Lakshmi Nambiar; Razia Sultana; Michele Parker; Preston Cargile; Omar K Khalique; Martin B Leon; Dimitrios Karmpaliotis; Mark Ratcliffe; Robert Levine; William A Zoghbi; Richard B Devereux; Chaya S Moskowitz; Raymond Kim; Jonathan W Weinsaft Journal: JACC Cardiovasc Imaging Date: 2021-03-17
Authors: Damien Legallois; Amir Hodzic; Joachim Alexandre; Charles Dolladille; Eric Saloux; Alain Manrique; Vincent Roule; Fabien Labombarda; Paul Milliez; Farzin Beygui Journal: Heart Fail Rev Date: 2022-01 Impact factor: 4.214
Authors: Wobbe Bouma; Hendrik M Willemsen; Chris P H Lexis; Niek H Prakken; Erik Lipsic; Dirk J van Veldhuisen; Massimo A Mariani; Pim van der Harst; Iwan C C van der Horst Journal: Clin Res Cardiol Date: 2016-06-08 Impact factor: 5.460
Authors: Ahmed S Fahmy; Ulf Neisius; Connie W Tsao; Sophie Berg; Elizabeth Goddu; Patrick Pierce; Tamer A Basha; Long Ngo; Warren J Manning; Reza Nezafat Journal: J Cardiovasc Magn Reson Date: 2018-03-22 Impact factor: 5.364